Best Smart Beta ETFs for Your Investment Portfolio
If you’re intrigued by the concept of smart beta, consider these exchange-traded funds.
Investors have been flocking to index funds, both mutual and exchange-traded versions, in ever-increasing numbers. In doing so, they’ve yanked tens of billions of dollars out of actively managed funds, which try to beat an index and normally charge more than unmanaged index funds.
But a hybrid type of fund—part index fund and part actively managed fund—is also making a bid for investor assets. Whether they’re called “smart beta,” “strategic beta” or one of several other names, you’ll want to understand them. Some are good investments.
What’s smart beta (the term I’ll use for simplicity’s sake)? Index funds, such as those that track Standard & Poor’s 500-stock index, weight their holdings according to a security’s market value. In the case of stock index funds, holdings are weighted by market capitalization. A stock’s market cap, or value, is simply the number of shares outstanding multiplied by the share price. So the most popular stocks, the ones with the highest market caps, get the biggest weightings. In the S&P 500, Apple (symbol AAPL) has the biggest market cap, $612 billion, and consequently has the index’s biggest weighting, 3.4% of assets. (Figures are as of April 12.)
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Smart beta mavens look at a capitalization-weighted index and ask, “Isn’t there a more intelligent way to select and weight stocks in an index than investor popularity?” They’ve come up with a cornucopia of ways to slice and dice the stock market to try to best conventional indexes.
And asset-management firms have taken smart beta ideas and turned them into products, mostly exchange-traded funds, that track these rules-based indexes. The funds don’t pay generous salaries to managers and analysts to kick the tires of individual companies. Instead, the funds overweight stocks that academics have shown produce heftier gains historically or less severe losses than index funds. Smart beta funds charge a bit more than index funds but much less than most actively managed funds.
Below are four types of smart beta funds, together with my favorites in each category. As with any type of fund, stick with those that charge the least. “Fees matter a lot,” says Alex Bryan, a Morningstar analyst.
Value. Stocks that are cheap in relation to the underlying company’s profits, revenues, book value (assets minus liabilities) or other factors tend to provide healthier returns than other stocks. However, value, like all other strategies, can flounder for many years at a time. In fact, value stocks have badly lagged growth stocks (companies with above-average growth) since 2005. That makes this a good time to start building a position in bargain stocks because an investing style that has lagged for years often bounces back strongly.
Among value ETFs, my favorite is iShares MSCI USA Value Factor ETF (VLUE). Since the fund’s inception in mid 2013, it has, as you’d expect, lagged the S&P 500, by an average of 3.0 percentage points per year. It invests in cheap stocks, but it doesn’t overweight broad industry sectors. The ETF charges just 0.15% in annual expenses.
Quality. I’ve been a longtime proponent of “high-quality” stocks, meaning companies with relatively high and stable earnings growth, low debt, and rising and sustainable dividend payouts. High-quality stocks tend to fall less than other stocks during bear markets, but expect them to lag in strong bull markets. One negative: Quality stocks have become so popular that they’re a little pricier than usual.
Good quality ETFs include Vanguard Dividend Appreciation (VIG) and Schwab US Dividend Equity ETF (SCHD). They charge annual fees of just 0.15% and 0.07%, respectively. But my favorite fund for high quality is an actively managed one, Vanguard Dividend Growth (VDIGX). Manager Don Kilbride and his team put a strong emphasis on quality factors. The fund, a member of the Kiplinger 25, has beaten the two ETFs over the past three years, exhibits slightly lower volatility and, with an annual expense ratio of 0.33%, doesn’t charge much more than the ETFs.
Low volatility. Don’t expect sizzling returns with low-volatility stocks in a hard-charging bull market. But low-vol stocks should do better in crummy markets. From my experience, most investors would accept that trade-off any day. My pick in this area is iShares MSCI USA Minimum Volatility (USMV). It doesn’t make huge sector bets, but it typically overweights health care, consumer staples and utility stocks. The ETF charges 0.15% per year.
Momentum. Newton’s law, believe it or not, tends to work with stocks. A stock that has gone up (or down) will tend to continue in that direction, at least for a while. I’m not a big fan of momentum strategies, but if you are, consider iShares MSCI USA Momentum Factor ETF (MTUM), which targets stocks that have posted good returns over the most recent six and 13 months, excluding the most recent month. That’s what the studies show works best.
But almost all studies are based on back testing—that is, looking at how a particular strategy would have done in the past. The more complex a back test, (see the paragraph above), the less likely that the strategy will actually work.
Want an ETF that employs all four of the strategies described above? Consider Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC). Charging just 0.09% annually, the ETF makes modest bets using all four factors. I’d be surprised if it beat the S&P by more than one-half or one percentage point per year, but I’d be equally surprised if the fund lagged badly.
Steve Goldberg is an investment adviser in the Washington, D.C., area.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
-
Stock Market Today: Stocks End Higher in Whipsaw Session
The main indexes were volatile Thursday with Nvidia earnings in focus.
By Karee Venema Published
-
Trump Picks Dr. Oz as Head of Medicare and Medicaid
President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
By Kathryn Pomroy Published
-
ESG Gives Russia the Cold Shoulder, Too
ESG MSCI jumped on the Russia dogpile this week, reducing the country's ESG government rating to the lowest possible level.
By Ellen Kennedy Published
-
Morningstar Fund Ratings Adopt a Stricter Curve
investing Morningstar is in the middle of revamping its fund analysts' methodology. Can they beat the indices?
By Steven Goldberg Published
-
Market Timing: The Importance of Doing Nothing
Investor Psychology Investors, as a whole, actually earn less than the funds that they invest in. Here’s how to avoid that fate.
By Steven Goldberg Published
-
Commission-Free Trades: A Bad Deal for Investors
investing Four of the biggest online brokers just cut their commissions to $0 per transaction. Be careful, or you could be a big loser.
By Steven Goldberg Published
-
Vanguard Dividend Growth Reopens. Enter at Will.
investing Why you should consider investing in this terrific fund now.
By Steven Goldberg Published
-
Health Care Stocks: Buy Them While They're Down
investing Why this sector should outperform for years to come
By Steven Goldberg Published
-
Buy Marijuana Stocks Now? You'd Have to Be Stoned.
stocks Don't let your investment dollars go to pot
By Steven Goldberg Published
-
4 Valuable Lessons From the 10-Year Bull Market
Investor Psychology Anything can happen next, so you must be mentally prepared.
By Steven Goldberg Published